NPFCX
Price
$60.62
Change
+$0.36 (+0.60%)
Updated
Jan 23 closing price
Net Assets
147.67B
TRGLX
Price
$67.23
Change
+$0.42 (+0.63%)
Updated
Jan 23 closing price
Net Assets
7.11B
Ad is loading...

NPFCX vs TRGLX

Header iconNPFCX vs TRGLX Comparison
Open Charts NPFCX vs TRGLXBanner chart's image
American Funds New Perspective C
Price$60.62
Change+$0.36 (+0.60%)
VolumeN/A
Net Assets147.67B
T. Rowe Price Global Stock I
Price$67.23
Change+$0.42 (+0.63%)
VolumeN/A
Net Assets7.11B
NPFCX vs TRGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NPFCX vs. TRGLX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPFCX is a StrongBuy and TRGLX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 148B vs. TRGLX (7.11B). TRGLX pays higher dividends than NPFCX: TRGLX (0.33) vs NPFCX (0.20). NPFCX was incepted earlier than TRGLX: NPFCX (24 years) vs TRGLX (8 years). TRGLX is a more actively managed with annual turnover of: 102.50 vs. NPFCX (17.00). NPFCX has a lower initial minimum investment than TRGLX: NPFCX (250) vs TRGLX (500000). TRGLX annual gain was more profitable for investors over the last year : 16.06 vs. NPFCX (15.26). TRGLX return over 5 years is better than : 41.18 vs. NPFCX (30.44).
NPFCXTRGLXNPFCX / TRGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years8 years-
Gain YTD4.0765.84670%
Front LoadN/AN/A-
Min. Initial Investment2505000000%
Min. Initial Investment IRAN/AN/A-
Net Assets148B7.11B2,080%
Annual Yield % from dividends0.200.3359%
Returns for 1 year15.2616.0695%
Returns for 3 years5.8415.3238%
Returns for 5 years30.4441.1874%
Returns for 10 years69.40N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTCR1.690.07
+4.32%
Heartcore Enterprises
PEBO32.200.85
+2.71%
Peoples Bancorp
CLVT5.440.08
+1.49%
Clarivate Plc
CRDF3.540.02
+0.57%
Cardiff Oncology
CQP60.51-2.28
-3.63%
Cheniere Energy Partners LP